NYXH
NyxoahยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NYXH Profile
Nyxoah Sa
A Belgian supplier of sleep apnea devices
Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium
--
Nyxoah SA was incorporated indefinitely in Belgium on July 15, 2009. The company is a medical technology company focused on the development and commercialization of innovative solutions for the treatment of obstructive sleep apnea (OSA). The company-led solution is the Genio System, a CE-marked, patient-centered, minimally invasive, next-generation hypoglossal nerve stimulation or HGNS therapy for the treatment of moderate to severe OSA. OSA is the most common sleep-disordered breathing disorder in the world and is associated with an increased risk of death and co-morbidities including cardiovascular disease, depression and stroke. The company's innovative technology platform is the first-of-its-kind HGNS device, designed to treat OSA through bilateral stimulation and achieve peaceful night sleep by keeping an open airway.
